Hypsizygus marmoreus polysaccharides protect against cisplatin-induced intestinal mucositis via modulation of gut microbiota, inflammation, and intestinal barrier function
Frontiers in Nutrition · 10.04.2026 · 13
DOI: 10.3389/fnut.2026.1774118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 10.04.2026. Verfasst von Mohammed Abusidu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian, Liaoning Province, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Provincial Department of Education, Chinese Scholarship Council.
Abstract (Originalsprache)
Introduction
Chemotherapy-induced intestinal mucositis is a frequent and debilitating complication of anticancer treatment, particularly with cisplatin, leading to disruption of the epithelial barrier, inflammation, and dysbiosis of the gut microbiota. Natural polysaccharides with antioxidant and immunomodulatory properties have attracted increasing attention as potential protective agents. This study investigated the protective effects of Hypsizygus marmoreus polysaccharides (HMP) against cisplatin-induced intestinal mucositis in mice.
Methods
HMP were extracted and structurally characterized through monosaccharide composition and molecular weight analysis. Antioxidant activity was evaluated using the ABTS + radical-scavenging assay. A cisplatin-induced mucositis mouse model was established to assess the protective effects of HMP on clinical symptoms, intestinal histopathology, inflammatory cytokines, epithelial barrier integrity, and gut microbiota composition using 16S rRNA sequencing.
Results
HMP were obtained at a yield of 16% and consisted mainly of glucose (52.44%) and galactose (21.05%), together with other monosaccharides, with a molecular weight of 752.96 kDa. In vitro , HMP exhibited concentration-dependent antioxidant activity, with ABTS + radical-scavenging increasing from 36.2% at 0.25 mg/mL to nearly 100% at≥20 mg/mL. In vivo , cisplatin administration induced body weight loss, diarrhea, immune organ atrophy, intestinal epithelial damage, and gut microbiota dysbiosis. HMP treatment significantly alleviated these alterations, improved intestinal histological structure, enhanced tight junction protein expression and mucin secretion, suppressed pro-inflammatory cytokines including IL-1β, IL-6, and TNF- α , and restored microbial diversity. Notably, beneficial taxa such as as Akkermansia muciniphila and Bifidobacterium pseudolongum were enriched following HMP administration.
Discussion
These findings indicate that HMP protects against cisplatin-induced intestinal mucositis through multiple complementary mechanisms, including antioxidant activity, suppression of inflammatory responses, preservation of epithelial barrier integrity, and modulation of gut microbiota composition. HMP therefore represents a promising natural candidate for mitigating chemotherapy-induced gastrointestinal toxicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, College of Basic Medical Science, Dalian Medical University, Dalian, Liaoning Province, China.
- The Marine Biomedical Research Institute of Guangdong Zhanjiang, School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang, Guangdong, China.
- Department of Laboratory Medicine Sciences, College of Medicine Faculty of Medical Sciences, Al-Aqsa University, Gaza, Palestine.
- Department of Pathogen Biology and Microecology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning Province, China.
- Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Dalian Medical University, Dalian, Liaoning Province, China.
- Department of Gastroenterology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Förderung
- Liaoning Provincial Department of Education
- Chinese Scholarship Council
Zitieren
APA
Abusidu, M., Alioui, Y., Al-Tibi, L., Alwayli, D., Ali, S., Rahman, M. U., Farooqui, N. A., Atta, A., Feng, B., Lu, S., & Wang, L. (2026). Hypsizygus marmoreus polysaccharides protect against cisplatin-induced intestinal mucositis via modulation of gut microbiota, inflammation, and intestinal barrier function. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1774118
Vancouver
Abusidu M, Alioui Y, Al-Tibi L, Alwayli D, Ali S, Rahman MU, et al. Hypsizygus marmoreus polysaccharides protect against cisplatin-induced intestinal mucositis via modulation of gut microbiota, inflammation, and intestinal barrier function. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1774118
BibTeX
@article{Abusidu2026,
author = {Abusidu, Mohammed and Alioui, Yamina and Al-Tibi, Lara and Alwayli, Dhafer and Ali, Sharafat and Rahman, Mujeeb Ur and Farooqui, Nabeel Ahmed and Atta, Aamna and Feng, Bin and Lu, Shuming and Wang, Liang},
title = {Hypsizygus marmoreus polysaccharides protect against cisplatin-induced intestinal mucositis via modulation of gut microbiota, inflammation, and intestinal barrier function},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1774118}
}
EUVIMED